The Journal of Experimental Medicine
ReproCELL
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 600K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corazza, N.
Right arrow Articles by Mueller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corazza, N.
Right arrow Articles by Mueller, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/1999/11/1479/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 10, November 15, 1999 1479-1492


Original Article

Nonlymphocyte-derived Tumor Necrosis Factor Is Required for Induction of Colitis in Recombination Activating Gene (RAG)2-/- Mice upon Transfer of CD4+CD45RBhi T Cells

Nadia Corazzaa, Susanne Eichenbergera, Hans-Pietro Eugsterb, and Christoph Muellera
a Institute of Pathology, Division of Immunopathology, University of Bern, CH-3010 Bern, Switzerland
b Department of Internal Medicine, University Hospital Zurich, CH-8057 Zurich, Switzerland

Correspondence to: Christoph Mueller, Institute of Pathology, Div. of Immunopathology, Murtenstrasse 31, CH-3010 Bern, Switzerland. Tel:41-31-632-89-04 Fax:41-31-381-87-64 E-mail:christoph.mueller{at}pathology.unibe.ch.

In this study, we addressed the role of tumor necrosis factor (TNF)-{alpha} and lymphotoxin (LT)-{alpha} in the development of colitis and defined the cellular sources (T cells versus non-T cells) of TNF (TNF-{alpha} and LT-{alpha}) relevant to disease development. After adoptive transfer of TNF+/+ CD4+CD45RBhi splenocytes into TNF+/+ recombination activating gene (RAG)2-/- mice, the recipients develop massive inflammation of the large intestinal mucosa concurrent with massive weight loss. In contrast, clinical signs of disease are completely absent in TNF-/-RAG2-/- recipients of TNF-/- CD4+CD45RBhi T cells, although elevated numbers of interferon-{gamma}–producing cells are present in the colonic mucosa. Surprisingly, upon transfer of TNF-/-CD4+CD45RBhi T cells into TNF+/+RAG2-/- recipients, colitis develops with kinetics similar to those upon transfer of TNF+/+CD4+CD45RBhi donor cells. In contrast, no clinical signs of colitis are observed in TNF-/-RAG2-/- recipients of TNF+/+CD4+CD45RBhi T cells. This protection from colitis is not a consequence of the absence of LT-{alpha}, as TNF-{alpha}-/-RAG2-/- recipients of TNF-{alpha}-/- CD4+CD45RBhi T cells are also protected from colitis induction. These results demonstrate the importance of TNF production by non-T cells of the colonic mucosa in the pathogenesis of colitis and provide direct evidence for a nonredundant role of TNF-{alpha} in this mouse model of colitis.

Key Words: inflammatory bowel disease, mucosal immunity, intestinal inflammation, proinflammatory cytokines


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS